Attention: You are using an outdated browser, device or you do not have the latest version of JavaScript downloaded and so this website may not work as expected. Please download the latest software or switch device to avoid further issues.
The 3.8 Initiative, named for the March 8 International Women's Day, seeks to increase start-up board leadership for women in Chicago's life science and health tech innovation ecosystem. The three key pillars of the program include:
Each cohort participates in several workshops and engage with subject matter experts outlining content relevant to startup board governance and leadership seminars.
Curriculum
Board Observance
Participants are given opportunities to observe startup board meetings as part of the program's experiential learning. Local incubators and the broader innovation ecosystem are supporting this initiative by providing access to startups for observance in this program.
 |
Simone Arvisais-Anhalt, MD
Director, Informatics
UCSF
 |
Paula Burris, MBA
Chief Marketing Officer
Advisor/NP Board
 |
Nina Dudnik, PhD
Sr Commercialization Advisor
Noble Reach
 |
Cathleen Dohrn, PhD
VP, Medical Strategy
Eversana Intouch
 |
Tracy Henriques, PhD
Director, Toxicology
AbbVie
 |
Alina Fernandez, MD, MBA, MPH
VP, Pharmacovigilence
Sunovion
 |
Cindy Johnson, MHA
Managing Director
BCBS
 |
Stacy Weil, PhD
Senior VP
Premier Research
 |
Shaina Barnes
Founder & CEO
SB Pharma Solutions
 |
Adrienne Gawlowski
SVP, Management Director
FCBCURE
 |
Jennifer Nardini
Asset Strategy Leader
AbbVie
 |
Alicja (Ala) Santos
CEO
Polonium Foundation
 |
Ngan MacDonald
Chief of Data Operations
Inst. for Augmented Intel in Medicine Northwestern
 |
Sharon (Shari) Medendorp
President & EVP
Premier Consulting
 |
Mel Sorenson
Director, Strategic Partnerships
BCBSA
 |
Nancy Hedlund
Founder, Managing Director
MedNavigate
 |
Valencia Wilson
Director, Patient Centricity
Astellas
 |
Kate Liebelt
Chief of Staff
Exec Director
Organon
 |
Anjali Goal
Head of Global Market Insights & Strategy
Hollister
 |
Vanessa Rath Menton
Sr. Director & US Commercial Lead
Astellas
 |
Farah Ali
VP, Clinical Development
Amgen
 |
Jami Ellis
Vice President,
New Product Planning
Amgen
 |
Izabella Tyzler
Biopharm. Commercial Exec.
IMT BioPharma Consulting
 |
Christine Rohan
CEO
Vasowatch
 |
Azurii Collier
Dir. of Enterprise Innovation
AbbVie
 |
Rachel Zimet Strick
Head of Immun. Bus. Dev & Acquisitions
AbbVie
 |
Natalya Pavchinskaya
AVP Foundational Platforms
Merck
 |
Anna Lisa Somera
CEO
Rhaeos, Inc.
 |
Paola Wisner
VP, Global R&D
Hologic
 |
Melissa Byrn
Assistant Dean,
Clinical Research
University of Chicago
 |
Marissa Haas
Asset Strategy Leader
AbbVie
 |
Angela James
Vice President, Head of Clinical Pharmacology
MacroGenics, Inc
 |
Katie Arnold
Founder & CEO
SPRIG Consulting
 |
Esther Barron
Director
Entrepreneurship
Law Center
Northwestern
 |
Shahila M Christie
VP, Growth Strategy & Operations
Portal Innovations
 |
Tina Esposito
System VP,
Chief Health
Information Officer
Advocate Aurora Health
 |
Heather Holmes
CEO &
Founder
Genivity
 |
Jennifer Lee
SVP, Drug Development
Elevar Therapeutics
 |
Beata Dowling
VP Financial Planning &
Analysis
Amgen
 |
Evonne Sepsis
Founder
ESC Advisors
 |
Heather Walsh
Exec. Dir, Head of New Bus. Opportunities
Rx+ Business Accelerator at Astellas
 |
Lilli Zakarija
Co-Founder & CEO
EdgeOne Medical
|